Clinical Trial Update: Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 safety study of ME-609 for the treatment of herpes simplex labialis in adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Labialis

Drugs mentioned

• ME-609

Snippet

Sponsor: Medivir | Conditions: Herpes Labialis | Phase 3 | Status: COMPLETED